Jean Kadouche

467 total citations
22 papers, 321 citations indexed

About

Jean Kadouche is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Jean Kadouche has authored 22 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Jean Kadouche's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Immune Cell Function and Interaction (6 papers) and RNA modifications and cancer (4 papers). Jean Kadouche is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Immune Cell Function and Interaction (6 papers) and RNA modifications and cancer (4 papers). Jean Kadouche collaborates with scholars based in France, Israel and Switzerland. Jean Kadouche's co-authors include Mercedes García‐González, Simon Benita, Philippe Pouletty, Nir Debotton, P Pouletty, Didier Decaudin, Stephen J. Mather, Ciara Finucane, Grégory Lambert and Taher Nassar and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Jean Kadouche

22 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Kadouche France 11 124 119 73 72 44 22 321
Vlastimil Král Czechia 13 124 1.0× 213 1.8× 143 2.0× 52 0.7× 68 1.5× 36 510
Nural Orgun United States 10 157 1.3× 77 0.6× 110 1.5× 177 2.5× 8 0.2× 14 449
J. P. Albert United States 5 31 0.3× 133 1.1× 36 0.5× 78 1.1× 26 0.6× 6 379
Margaret E. McCoy United States 7 30 0.2× 162 1.4× 44 0.6× 202 2.8× 77 1.8× 7 390
Erica Browning United States 6 84 0.7× 270 2.3× 93 1.3× 453 6.3× 53 1.2× 11 714
Frans Nauwelaers Germany 10 27 0.2× 250 2.1× 52 0.7× 84 1.2× 14 0.3× 19 453
Sumit Majumdar United States 9 99 0.8× 267 2.2× 72 1.0× 66 0.9× 65 1.5× 16 428
Shirley I. Miekka United States 8 99 0.8× 201 1.7× 32 0.4× 42 0.6× 21 0.5× 14 524
Scott H. Stansfield Australia 11 179 1.4× 478 4.0× 105 1.4× 36 0.5× 21 0.5× 14 674
Tom J.M. Molenaar Netherlands 10 114 0.9× 192 1.6× 28 0.4× 78 1.1× 36 0.8× 14 368

Countries citing papers authored by Jean Kadouche

Since Specialization
Citations

This map shows the geographic impact of Jean Kadouche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Kadouche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Kadouche more than expected).

Fields of papers citing papers by Jean Kadouche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Kadouche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Kadouche. The network helps show where Jean Kadouche may publish in the future.

Co-authorship network of co-authors of Jean Kadouche

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Kadouche. A scholar is included among the top collaborators of Jean Kadouche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Kadouche. Jean Kadouche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khairnar, Vishal, et al.. (2024). 1074 Reversal of resistance to PD-1 checkpoint blockade in hepatocellular carcinoma by NY-303, a GPC3 NK cell engager, inhibiting Wnt-GPC3-beta catenin signaling. Regular and Young Investigator Award Abstracts. A1195–A1195. 1 indexed citations
2.
Lin, Liang, Hao‐Ming Chang, Martine Duonor-Cérutti, et al.. (2023). Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3. Cells. 12(7). 996–996. 20 indexed citations
3.
4.
5.
Loisel, Séverine, Josée Golay, Franz Buchegger, et al.. (2011). Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia. Molecular Cancer. 10(1). 42–42. 19 indexed citations
6.
Debotton, Nir, et al.. (2009). A quantitative evaluation of the molecular binding affinity between a monoclonal antibody conjugated to a nanoparticle and an antigen by surface plasmon resonance. European Journal of Pharmaceutics and Biopharmaceutics. 74(2). 148–156. 21 indexed citations
7.
Debotton, Nir, et al.. (2008). Overcoming the formulation obstacles towards targeted chemotherapy: In vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles. Journal of Controlled Release. 127(3). 219–230. 28 indexed citations
8.
Decaudin, Didier, et al.. (2007). Radioimmunotherapy of refractory or relapsed Hodgkin's lymphoma with 90Y-labelled antiferritin antibody. Anti-Cancer Drugs. 18(6). 725–731. 8 indexed citations
9.
Decaudin, Didier, Ronald Levy, François Lokiec, et al.. (2007). P38 Radioimmunotherapy (RIT) of refractory or relapsed Hodgkin's lymphoma (HL) with 90Yttrium-labelled antiferritin antibody. European Journal of Cancer Supplements. 5(8). 23–24. 1 indexed citations
10.
Kadouche, Jean, et al.. (2007). In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer. Nuclear Medicine and Biology. 34(3). 293–304. 28 indexed citations
11.
Decaudin, Didier, et al.. (2007). Radioimmunotherapy (RIT) of Refractory or Relapsed Hodgkin’s Lymphoma (HL) with 90Yttrium-Labelled Antiferritin Antibody.. Blood. 110(11). 4473–4473. 1 indexed citations
12.
Sarde, Claude‐Olivier, et al.. (2005). Antitumor Response Against Myeloma Cells by Immunization with Mouse Syngenic Dendritoma. Hybridoma. 24(4). 182–188. 5 indexed citations
13.
Goldstein, D. J., Taher Nassar, Grégory Lambert, Jean Kadouche, & Simon Benita. (2005). The design and evaluation of a novel targeted drug delivery system using cationic emulsion–antibody conjugates. Journal of Controlled Release. 108(2-3). 418–432. 24 indexed citations
14.
Pouletty, P, et al.. (1988). Optimization of a rapid test by using fluorescein-conjugated monoclonal antibodies for detection of Chlamydia trachomatis in clinical specimens. Journal of Clinical Microbiology. 26(2). 267–270. 6 indexed citations
15.
García‐González, Mercedes, et al.. (1988). Purification of murine IgG3 and IgM monoclonal antibodies by euglobulin precipitation. Journal of Immunological Methods. 111(1). 17–23. 71 indexed citations
16.
Pouletty, P, et al.. (1987). Detection of herpes simplex virus in direct specimens by immunofluorescence assay using a monoclonal antibody. Journal of Clinical Microbiology. 25(5). 958–959. 19 indexed citations
17.
Pouletty, P, Jean Kadouche, Mercedes García‐González, et al.. (1985). An anti-human μ chain monoclonal antibody: Use for detection of IgM antibodies to toxoplasma gondii by reverse immunosorbent assay. Journal of Immunological Methods. 76(2). 289–298. 18 indexed citations
18.
Pouletty, P, J. M. Pinon, Mercedes García‐González, et al.. (1984). An anti-human immunoglobulin M monoclonal antibody for detection of antibodies toToxoplasma gondii. European Journal of Clinical Microbiology & Infectious Diseases. 3(6). 510–515. 3 indexed citations
19.
Kadouche, Jean, et al.. (1984). Analysis of Various Isoferritins with Monoclonal Antibodies. 187–190. 2 indexed citations
20.
Dresch, C, A Faille, Odette Poirier, & Jean Kadouche. (1974). The cellular composition of the granulocyte series in the normal human bone marrow according to the volume of the sample. Journal of Clinical Pathology. 27(2). 106–108. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vlastimil Král Breakdown of academic impact, for papers by Nural Orgun Breakdown of academic impact, for papers by J. P. Albert Breakdown of academic impact, for papers by Margaret E. McCoy Breakdown of academic impact, for papers by Erica Browning Breakdown of academic impact, for papers by Frans Nauwelaers Breakdown of academic impact, for papers by Sumit Majumdar Breakdown of academic impact, for papers by Shirley I. Miekka Breakdown of academic impact, for papers by Scott H. Stansfield Breakdown of academic impact, for papers by Tom J.M. Molenaar
Rankless by CCL
2026